ZHOU, RONGXIA – Trademark Portfolio

Entity Type: 01

ZHOU, RONGXIA owns a portfolio of 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as ZOOBELIO, ISLANDEAR, and LOOSEN SOUL. Of these, 3 are registered. The portfolio spans 3 Nice Classification classes, led by Class 21 (Housewares) and Class 10 (Medical Apparatus). Headquartered in LESHAN CITY.

NO. 286, GROUP 6, BAOXING VILLAGE, QINGPING TOWN, SHIZHONG DISTRICT

LESHAN CITY 614000 , CN

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

ZHOU, RONGXIA's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

21
Housewares (1 filing)

Household or kitchen utensils and containers; combs and sponges; brushes

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does ZHOU, RONGXIA have?

ZHOU, RONGXIA has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does ZHOU, RONGXIA file in?

ZHOU, RONGXIA files trademarks across 3 Nice Classification classes. The most active classes are Class 21 (Housewares), Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 21 covers household or kitchen utensils and containers; combs and sponges; brushes.

What are ZHOU, RONGXIA's most well-known trademarks?

ZHOU, RONGXIA's registered trademark portfolio includes well-known marks such as ZOOBELIO, ISLANDEAR, and LOOSEN SOUL. These are among 3 currently registered trademarks in the portfolio.

What is ZHOU, RONGXIA's trademark registration success rate?

ZHOU, RONGXIA has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.